Bionomics Revenue 2022-2024 | NEUP
Bionomics revenue from 2022 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Bionomics Annual Revenue
(Millions of US $) |
| 2024 |
$ |
| 2023 |
$ |
| 2022 |
$0 |
| 2021 |
$ |
Bionomics Quarterly Revenue
(Millions of US $) |
| 2024-09-30 |
|
| 2024-06-30 |
|
| 2023-12-31 |
|
| 2023-09-30 |
|
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.010B |
$0.000B |
|
Bionomics Limited is a clinical-stage biopharmaceutical developing novel, allosteric ion channel modulators designed to transform the lives of patients suffering from serious central nervous system disorders. Bionomics Limited is based in ADELAIDE, Australia.
|
